Genomic Valley Biotech

58.59
-3.08
(-4.99%)
Market Cap
17.86 Cr
EPS
0.05
PE Ratio
48.94
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
108.15
52 Week Low
28.36
PB Ratio
4.93
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
279.45
#1 3,126.50
21.63
#1 660.50
#1 16.68
#1 137
-8.47
44.59
33.97
57.29
#1 8.52
45.50
-13.00
3
-38.46
32.30
0.90
35.90
18.20
21.30
-66.19
1
#1 700.00
31.91
58.59
#4 17.86
#4 48.94
#4 0.20
#4 -92.86
0
#2 0.20
45.35
Growth Rate
Revenue Growth
-92.86 %
Net Income Growth
-100.00 %
Cash Flow Change
97.44 %
ROE
-97.66 %
ROCE
-97.66 %
EBITDA Margin (Avg.)
-70.73 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
0
1
1
1
1
0
0
3
0
1
Expenses
0
1
1
1
1
0
0
0
2
0
0
EBITDA
0
-0
0
0
0
1
-0
-0
1
0
1
Operating Profit %
-249 %
-422 %
-23 %
17 %
42 %
65 %
-66 %
-535 %
32 %
9 %
56 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
-0
0
0
0
-1
0
1
0
1
Tax
0
0
0
0
0
-0
0
0
0
0
0
Net Profit
0
-0
-0
0
0
0
-1
0
1
0
1
EPS in ₹
-0.03
-1.10
-0.22
0.11
0.76
0.94
-1.83
-0.03
2.12
0.05
1.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
6
6
6
7
7
8
8
4
4
4
Fixed Assets
3
3
4
4
4
5
6
2
0
0
Current Assets
0
0
0
0
0
0
0
1
3
3
Capital Work in Progress
0
0
0
0
1
1
1
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
3
3
2
2
2
3
1
2
4
4
Total Liabilities
6
6
6
7
7
8
8
4
4
4
Current Liabilities
1
1
1
1
0
1
1
0
1
1
Non Current Liabilities
1
1
1
1
2
2
2
1
0
0
Total Equity
5
5
5
5
5
5
5
3
4
4
Reserve & Surplus
2
2
1
2
2
2
1
-0
1
1
Share Capital
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
0
0
0
0
0
0
0
0
Investing Activities
-1
1
-0
-1
0
-1
-2
4
2
0
Operating Activities
0
-1
0
1
-1
0
2
-2
-1
0
Financing Activities
0
0
0
0
1
0
0
-2
-1
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
67.85 %
67.85 %
67.85 %
67.85 %
67.85 %
67.85 %
67.85 %
67.85 %
67.18 %
67.18 %
66.32 %
65.04 %
64.20 %
64.14 %
54.67 %
46.83 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.15 %
32.15 %
32.15 %
32.15 %
32.15 %
32.15 %
32.15 %
32.15 %
32.17 %
32.17 %
32.66 %
32.70 %
34.45 %
35.06 %
44.74 %
52.59 %
Others
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.65 %
0.65 %
1.02 %
2.25 %
1.35 %
0.81 %
0.59 %
0.58 %
No of Share Holders
0
371
371
371
371
371
375
375
380
381
591
1,014
1,334
1,540
2,128
2,497

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Integrated Filing (Financial)Feb 14, 2025
Financial Results For The Quarter And Nine Month Ended 31St December2024Feb 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Held Today I.E. 14Th February 2025 Read With Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) ReFeb 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations2015.Feb 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJan 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportDec 31, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMDec 30, 2024
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 09, 2024
Notice Of The Annual General MeetingDec 07, 2024
Reg. 34 (1) Annual Report.Dec 07, 2024
Book Closure IntimationDec 06, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementDec 06, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Dated 06-12-2024Dec 06, 2024
Board Meeting Intimation for Notice Of Board Meeting Of The Company Under Regulation 29 Of The Securities And Exchange Board Of India (LODR) Regulations,2015Dec 02, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 28, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 21, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 18, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 18, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 18, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 08, 2024
Please Find Enclosed Herewith Un Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th ,2024Oct 07, 2024
Board Meeting Outcome for Please Find Enclosed Herewith Outcome Of Board Meeting Pusuant To Regulation 30 Of Sebi ( LODR)Regulation ,2015 Held On Today I.E. 07Th October 2024Oct 07, 2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015Oct 03, 2024
Closure of Trading WindowSep 30, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 19, 2024
Intimation Of Approval Of Extension Of Time For Holding Annual General Meeting (AGM) Of The Company For The Financial Year Ended 31St March, 2024 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015Sep 11, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On September 05, 2024Sep 06, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 04, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 26, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 01, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 01, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2024
Submission Of Un-Audited Standalone Financial Results For The Quarter Ended On June 30, 2024Jul 29, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E., 29Th July, 2024Jul 29, 2024
Board Meeting Intimation for Intimation Regarding Holding Of Board Meeting On 29Th July, 2024 To Consider Un-Audited Financial Results For The Quarter Ended June 30, 2024Jul 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2024
Closure of Trading WindowJun 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2024
Non-Applicability Of Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015May 09, 2024
Audited Financial Results For The Period Ended March 31, 2024May 09, 2024
Board Meeting Outcome for Outcome Of Board MeetingMay 09, 2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015May 03, 2024
Compliance Certificate Under Reg 40(10) Of LODR Reg.Apr 30, 2024
Compliance Certificate Under Reg. 7(3) Of LODR Reg, 2015Apr 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 21, 2024

Technical Indicators

RSI(14)
Neutral
45.35
ATR(14)
Less Volatile
2.31
STOCH(9,6)
Neutral
59.63
STOCH RSI(14)
Oversold
17.80
MACD(12,26)
Bullish
0.08
ADX(14)
Weak Trend
17.98
UO(9)
Bearish
47.61
ROC(12)
Uptrend And Accelerating
1.02
WillR(14)
Oversold
-94.11